These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1359114)

  • 21. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists.
    Szabo S; Reichlin S
    Regul Pept; 1983 Apr; 6(1):43-9. PubMed ID: 6135242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
    Kondo M; Kodama H; Costa T; Shimohigashi Y
    Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sulphydryl compounds in the defense of rat gastric epithelial cells against oxygen reactive metabolite-induced damage.
    Romano M; Razandi M; Ivey KJ
    Ital J Gastroenterol; 1991 Feb; 23(2):55-9. PubMed ID: 1747503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteamine induces cholecystokinin release from the duodenum. Evidence for somatostatin as an inhibitory paracrine regulator of cholecystokinin secretion in the rat.
    Abucham J; Reichlin S
    Gastroenterology; 1990 Dec; 99(6):1633-40. PubMed ID: 1699833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of cysteamine on duodenal alkaline phosphatase.
    Japundzić I; Levi E
    Biochem Pharmacol; 1987 Aug; 36(15):2489-95. PubMed ID: 3606652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats.
    Vécsei L; Alling C; Heilig M; Widerlöv E
    Pharmacol Biochem Behav; 1989 Mar; 32(3):629-35. PubMed ID: 2568000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OLD AND NEW NEUROENDOCRINE MOLECULES: SOMATOSTATIN, CYSTEAMINE, PANTETHINE AND KYNURENINE.
    Vécsei L; Horváth Z; Tuka B
    Ideggyogy Sz; 2014 Mar; 67(3-4):107-12. PubMed ID: 26118251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
    Sagar SM; Landry D; Millard WJ; Badger TM; Arnold MA; Martin JB
    J Neurosci; 1982 Feb; 2(2):225-31. PubMed ID: 6121016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cysteamine on cytosolic somatostatin binding sites in rabbit duodenal mucosa.
    Gonzalez-Guijarro L; Lopez-Ruiz MP; Bodegas G; Prieto JC; Arilla E
    Exp Mol Pathol; 1987 Apr; 46(2):153-8. PubMed ID: 2881805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventromedial hypothalamic somatostatin may affect gastric somatostatin concentration in rats.
    Qu F; Bai B; Zhu HN
    Neuropeptides; 1990 Jun; 16(2):97-101. PubMed ID: 1979157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and radioprotective activity of new cysteamine and cystamine derivatives.
    Oiry J; Pue JY; Imbach JL; Fatome M; Sentenac-Roumanou H; Lion C
    J Med Chem; 1986 Nov; 29(11):2217-25. PubMed ID: 3023610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships for ulcerogenic and adrenocorticolytic effects of alkyl nitriles, amines, and thiols.
    Szabo S; Reynolds ES
    Environ Health Perspect; 1975 Jun; 11():135-40. PubMed ID: 1175550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of tissueculture cells against ionizing radiation. I. The effect of biological amines, disulphide compounds and thiols.
    VOS O; BUDKE L; VERGROESEN AJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1962 Oct; 5():543-57. PubMed ID: 13997936
    [No Abstract]   [Full Text] [Related]  

  • 35. Cystamine and cysteamine as inhibitors of transglutaminase activity
    Jeitner TM; Pinto JT; Cooper AJL
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasomotor properties of mercaptoethylguanidine (MEG) in the rat].
    Lecomte J; Bacq ZM
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):480-97. PubMed ID: 4161764
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of cysteamine on suckling-induced prolactin secretion in the rat.
    Millard WJ; O'Sullivan D; Riskind PN
    Life Sci; 1987 Nov; 41(20):2255-60. PubMed ID: 3683075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological effects of cysteamine: relationship to somatostatin depletion.
    Brown MR; Fisher LA; Sawchenko PE; Swanson LW; Vale WW
    Regul Pept; 1983 Jan; 5(2):163-79. PubMed ID: 6131501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Drug Chem Toxicol; 1985; 8(6):483-94. PubMed ID: 4092620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible inactivation of calcium-dependent proteinases from rat liver by biological disulfides.
    Di Cola D; Sacchetta P
    FEBS Lett; 1987 Jan; 210(1):81-4. PubMed ID: 3026839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.